Skip to main content
Valiant Laboratories Limited logo

Valiant Laboratories Limited — Investor Relations & Filings

Ticker · VALIANTLAB ISIN · INE0JWS01017 LEI · 335800VKNJKWJ4LD6855 BSE.NS Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2024-04-08 Regulatory Filings
Country IN India
Listing BSE.NS VALIANTLAB

About Valiant Laboratories Limited

https://www.valiantlabs.in/

Valiant Laboratories Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs, with a primary focus on the production of Paracetamol. The company operates dedicated manufacturing facilities designed for the large-scale synthesis of analgesic and antipyretic compounds. By maintaining rigorous quality control standards and process efficiencies, it serves as a key supplier for formulations across various therapeutic segments. Its core business activities encompass the chemical processing and distribution of high-grade medicinal ingredients, catering to a diverse range of healthcare manufacturers. The organization prioritizes technical excellence in API synthesis and the optimization of production workflows to ensure a consistent supply of essential pharmaceutical components.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended March 31, 2024. It is addressed to stock exchanges and compliance departments and is issued by the company's registrar and share transfer agent. The document is short (3210 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of voting results, board changes, or capital changes. It is a regulatory filing confirming compliance with SEBI regulations related to securities dematerialisation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-04-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It confirms that no encumbrances were made on the shares by promoters or promoter group members during the financial year 2023-2024. The document includes a list of promoters and promoter group members as an annexure. This type of filing is a notification related to major shareholding and changes in share ownership or encumbrances, which fits the category of Major Shareholding Notification (MRQ). The document is not a report, financial statement, or announcement of voting results, but a regulatory declaration about shareholding status.
2024-04-03 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the resignation of the Company Secretary & Compliance Officer, Ms. Saloni Mehta. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content focuses on management change, specifically the resignation of a key officer, with details about the resignation date and reason. There is no financial data, earnings information, or report attached or referenced as being published. The document is clearly an announcement of a change in senior management rather than a financial report or other filing type. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (3011 characters), consistent with a management change announcement.
2024-03-29 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the trading window closure period related to the upcoming financial results announcement but does not contain any financial data or results itself. The document length is only 1217 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it is not an Annual Report, Earnings Release, or Interim Report. It is a regulatory compliance announcement related to insider trading rules and trading restrictions. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-27 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the newspaper publication of a Postal Ballot Notice. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulations 30 and 47, which pertain to disclosure of material events and publication of notices. The document does not contain any financial data, management discussion, voting results, or detailed report content. It is a short communication notifying the exchanges about the publication of a notice, which aligns with an announcement rather than the notice or report itself. Given the document length (2064 characters) and content, it fits the criteria for a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-03-08 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Notice of Postal Ballot issued by Valiant Laboratories Limited dated March 7, 2024. It references the Companies Act, 2013, SEBI Listing Regulations, and MCA circulars, indicating compliance with regulatory requirements for shareholder voting. The notice details the resolutions proposed for approval via electronic voting, including material related party transactions. It specifies the voting period and the process for remote e-voting, and mentions that the results will be announced after the voting period ends. The document is not a report itself but a formal notice to shareholders to vote on specific resolutions. It does not contain financial statements or management discussion but is a solicitation for shareholder approval through postal ballot. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2024-03-07 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.